BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 8565305)

  • 1. Administration of anti-CD3 monoclonal antibody during experimental Chagas' disease induces CD8+ cell-dependent lethal shock.
    Jacobs F; Dubois C; Carlier Y; Goldman M
    Clin Exp Immunol; 1996 Feb; 103(2):233-8. PubMed ID: 8565305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
    Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
    Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
    Muñoz-Fernández MA; Fernández MA; Fresno M
    Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi sensitizes mice to fulminant SEB-induced shock: overrelease of inflammatory cytokines and independence of Chagas' disease or TCR Vbeta-usage.
    Paiva CN; Pyrrho AS; Lannes-Vieira J; Vacchio M; Soares MB; Gattass CR
    Shock; 2003 Feb; 19(2):163-8. PubMed ID: 12578126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice.
    Florquin S; Amraoui Z; Dubois C; Decuyper J; Goldman M
    J Exp Med; 1994 Sep; 180(3):1153-8. PubMed ID: 7520469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice.
    Hölscher C; Mohrs M; Dai WJ; Köhler G; Ryffel B; Schaub GA; Mossmann H; Brombacher F
    Infect Immun; 2000 Jul; 68(7):4075-83. PubMed ID: 10858224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Most parasite-specific CD8+ cells in Trypanosoma cruzi-infected chronic mice are down-regulated for T-cell receptor-alphabeta and CD8 molecules.
    Grisotto MG; D'Império Lima MR; Marinho CR; Tadokoro CE; Abrahamsohn IA; Alvarez JM
    Immunology; 2001 Feb; 102(2):209-17. PubMed ID: 11260326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10.
    Donckier V; Flament V; Gérard C; Abramowicz D; Vandenabeele P; Wissing M; Delvaux A; Fiers W; Leo O; Velu T
    Transplantation; 1994 May; 57(10):1436-9. PubMed ID: 8197603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages.
    Silva JS; Vespa GN; Cardoso MA; Aliberti JC; Cunha FQ
    Infect Immun; 1995 Dec; 63(12):4862-7. PubMed ID: 7591147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
    Nickell SP; Sharma D
    Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection.
    Abrahamsohn IA; Coffman RL
    J Immunol; 1995 Oct; 155(8):3955-63. PubMed ID: 7561103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental African trypanosomiasis: a subset of pathogenic, IFN-gamma-producing, MHC class II-restricted CD4+ T cells mediates early mortality in highly susceptible mice.
    Shi M; Wei G; Pan W; Tabel H
    J Immunol; 2006 Feb; 176(3):1724-32. PubMed ID: 16424202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of T-cell subsets in the response to anti-CD3 monoclonal antibodies.
    Finck BK; Yung CM; Carteron NL; Wofsy D
    Clin Immunol Immunopathol; 1992 Dec; 65(3):234-41. PubMed ID: 1360341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation.
    Chaussabel D; Jacobs F; de Jonge J; de Veerman M; Carlier Y; Thielemans K; Goldman M; Vray B
    Infect Immun; 1999 Apr; 67(4):1929-34. PubMed ID: 10085038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids.
    Ferran C; Dy M; Merite S; Sheehan K; Schreiber R; Leboulenger F; Landais P; Bluestone J; Bach JF; Chatenoud L
    Transplantation; 1990 Oct; 50(4):642-8. PubMed ID: 1699310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anti-CD3 monoclonal antibody protects mice against a lethal infection with Listeria monocytogenes through induction of endogenous cytokines.
    Nakane A; Okamoto M; Asano M; Kohanawa M; Minagawa T
    Infect Immun; 1993 Jul; 61(7):2786-92. PubMed ID: 8514380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation-induced CD4+ T cell death by apoptosis in experimental Chagas' disease.
    Lopes MF; da Veiga VF; Santos AR; Fonseca ME; DosReis GA
    J Immunol; 1995 Jan; 154(2):744-52. PubMed ID: 7814881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi-induced immunosuppression: selective triggering of CD4+ T-cell death by the T-cell receptor-CD3 pathway and not by the CD69 or Ly-6 activation pathway.
    Lopes MF; DosReis GA
    Infect Immun; 1996 May; 64(5):1559-64. PubMed ID: 8613360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-mouse strain differences in the in vivo anti-CD3 induced cytokine release.
    Ferran C; Dy M; Sheehan K; Merite S; Schreiber R; Landais P; Grau G; Bluestone J; Bach JF; Chatenoud L
    Clin Exp Immunol; 1991 Dec; 86(3):537-43. PubMed ID: 1721015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities.
    Roggero E; Perez A; Tamae-Kakazu M; Piazzon I; Nepomnaschy I; Wietzerbin J; Serra E; Revelli S; Bottasso O
    Clin Exp Immunol; 2002 Jun; 128(3):421-8. PubMed ID: 12067296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.